Literature DB >> 6348172

A modified short-term cytotoxicity test: assessment of natural cell-mediated cytotoxicity in whole blood.

R C Rees, A A Platts.   

Abstract

Using whole blood from normal subjects, we have observed natural killing of K562 cells in a 4 h 51Cr-release assay comparable with that shown by separated PBMC and whole blood depleted of serum components. Separated plasma was not toxic towards K562 targets, and failed to potentiate the level of PBMC cytotoxicity through ADCC. The presence of red blood cells did not influence natural killing. The natural cytotoxicity of whole blood was augmented by interferon and depressed by prostaglandins E1 and E2. Studies with appropriate control blood fractions show that cytotoxicity tests with whole blood provide results reflecting natural cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348172     DOI: 10.1016/0022-1759(83)90113-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity.

Authors:  Neta Gotlieb; Ella Rosenne; Pini Matzner; Lee Shaashua; Liat Sorski; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2014-12-26       Impact factor: 7.217

2.  Human spleen cells mediating natural killing: altered natural cytotoxicity of spleen effector cells from patients with carcinoma.

Authors:  S A Ali; C M Hawrylowicz; J Peel; C Griffith; R C Ress
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  The nature of enhanced natural killer lymphocyte cytotoxicity during anesthesia and surgery in patients with benign disease and cancer.

Authors:  C D Griffith; R C Rees; A Platts; A Jermy; J Peel; K Rogers
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

4.  Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.

Authors:  K Shakhar; G Shakhar; E Rosenne; S Ben-Eliyahu
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.